Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

NCT02321501 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

ALK Positive
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
ROS1 Gene Rearrangement
Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions

DRUG: Ceritinib
DRUG: Everolimus
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]